Commentary: Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial

被引：0
|
作者：
Mazokopakis, Elias E. [1 ]
Papadomanolaki, Maria G. [2 ]
机构：
[1] Naval Hosp Crete, Dept Internal Med, Khania, Greece
[2] Tech Univ Crete, Sch Prod Engn & Management, Iraklion, Greece
来源：
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词：
Spirulina; Arthrospira platensis; supplementation; COVID-19; prevention; hospitalization; ARTHROSPIRA-PLATENSIS SUPPLEMENTATION; CRETAN POPULATION;
D O I：
10.3389/fimmu.2024.1417046
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial
    Aghasadeghi, Mohammad Reza
    Zaheri Birgani, Mohammad Ali
    Jamalimoghadamsiyahkali, Saeedreza
    Hosamirudsari, Hadiseh
    Moradi, Ali
    Jafari-Sabet, Majid
    Sadigh, Nooshin
    Rahimi, Pooneh
    Tavakoli, Rezvan
    Hamidi-Fard, Mojtaba
    Bahramali, Golnaz
    Parmoon, Zohal
    Arjmand Hashjin, Sina
    Mirzajani, Ghasem
    Kouhkheil, Reza
    Roshangaran, Somayeh
    Khalaf, Samineh
    Khademi Nadoushan, Mohammad
    Gholamiyan Yousef Abad, Ghazaleh
    Shahryarpour, Nima
    Izadi, Mohammad
    Zendedel, Abolfazl
    Jahanfar, Shayesteh
    Dadras, Omid
    SeyedAlinaghi, SeyedAhmad
    Hackett, Daniel
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [2] Efficacy and safety of vitamin D supplementation in hospitalized COVID-19 pediatric patients: A randomized controlled trial
    Zurita-Cruz, Jessie
    Fonseca-Tenorio, Jeffry
    Villasis-Keever, Miguel
    Lopez-Alarcon, Mardia
    Parra-Ortega, Israel
    Lopez-Martinez, Briceida
    Miranda-Novales, Guadalupe
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [3] A pilot double-blind safety and feasibility randomized controlled trial of high-dose intravenous zinc in hospitalized COVID-19 patients
    Patel, Oneel
    Chinni, Vidyasagar
    El-Khoury, John
    Perera, Marlon
    Neto, Ary S.
    McDonald, Christine
    See, Emily
    Jones, Daryl
    Bolton, Damien
    Bellomo, Rinaldo
    Trubiano, Jason
    Ischia, Joseph
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (05) : 3261 - 3267
  • [4] The Effect of Nanocurcumin Supplementation on Inflammatory and Biochemical Indicators in Hospitalized Patients With COVID-19: A Randomized Controlled Clinical Trial
    Ahmadi, Sedigheh
    Mohit, Mohsen
    Mehrabi, Zeinab
    Heydari, Mohammad Reza
    Faraji, Seyed Nooreddin
    Yaghoubi, Shoeleh
    Zare, Morteza
    Masoumi, Seyed Jalil
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2024, 2024 (01)
  • [5] COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial
    Annweiler, Cedric
    Beaudenon, Melinda
    Gautier, Jennifer
    Simon, Romain
    Dubee, Vincent
    Gonsard, Justine
    Parot-Schinkel, Elsa
    TRIALS, 2020, 21 (01)
  • [6] High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial
    Naik, Naveen B.
    Puri, Goverdhan D.
    Kajal, Kamal
    Mahajan, Varun
    Bhalla, Ashish
    Kataria, Sandeep
    Singla, Karan
    Panigrahi, Pritam
    Singh, Ajay
    Lazar, Michelle
    Chander, Anjuman
    Ganesh, Venkata
    Hazarika, Amarjyoti
    Suri, Vikas
    Goyal, Manoj K.
    Pandey, Vijayant Kumar
    Kaloria, Narender
    Samra, Tanvir
    Saini, Kulbhushan
    Soni, Shiv L.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [7] High-dose vitamin D supplementation in patients with COVID-19: A meta-analysis of randomized controlled trials
    Zhong, Zhaoshuang
    Zhao, Long
    Zhao, Yan
    Xia, Shuyue
    FOOD SCIENCE & NUTRITION, 2024, 12 (03): : 1808 - 1817
  • [8] COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial
    Cédric Annweiler
    Mélinda Beaudenon
    Jennifer Gautier
    Romain Simon
    Vincent Dubée
    Justine Gonsard
    Elsa Parot-Schinkel
    Trials, 21
  • [9] Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19 Blinded, Randomized, Placebo-Controlled Trial
    Self, Wesley H.
    Wheeler, Allison P.
    Stewart, Thomas G.
    Schrager, Harry
    Mallada, Jason
    Thomas, Christopher B.
    Cataldo, Vince D.
    O'Neal, Hollis R., Jr.
    Shapiro, Nathan, I
    Higgins, Conor
    Ginde, Adit A.
    Chauhan, Lakshmi
    Johnson, Nicholas J.
    Henning, Daniel J.
    Jaiswal, Stuti J.
    Mammen, Manoj J.
    Harris, Estelle S.
    Pannu, Sonal R.
    Laguio-Vila, Maryrose
    El Atrouni, Wissam
    de Wit, Marjolein
    Hoda, Daanish
    Cohn, Claudia S.
    McWilliams, Carla
    Shanholtz, Carl
    Jones, Alan E.
    Raval, Jay S.
    Mucha, Simon
    Ipe, Tina S.
    Qiao, Xian
    Schrantz, Stephen J.
    Shenoy, Aarthi
    Fremont, Richard D.
    Brady, Eric J.
    Carnahan, Robert H.
    Chappell, James D.
    Crowe, James E., Jr.
    Denison, Mark R.
    Gilchuk, Pavlo
    Stevens, Laura J.
    Sutton, Rachel E.
    Thomsen, Isaac
    Yoder, Sandra M.
    Bistran-Hall, Amanda J.
    Casey, Jonathan D.
    Lindsell, Christopher J.
    Wang, Li
    Pulley, Jill M.
    Rhoads, Jillian P.
    Bernard, Gordon R.
    CHEST, 2022, 162 (05) : 982 - 994
  • [10] NASAFYTOL® supplementation in adults hospitalized with COVID-19 infection: results from an exploratory open-label randomized controlled trial
    Gerain, Jean
    Uebelhoer, Melanie
    Costes, Berenice
    Herman, Julie
    Pietri, Sandra
    Donneau, Anne-Francoise
    Monseur, Justine
    Henrotin, Yves
    FRONTIERS IN NUTRITION, 2023, 10
12345